← All organizations

BerGenBio ASA

For profitWebsite ↗

Also known as: BerGenBio ASA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 31, 2022

Timeline

2000s

Jun 1, 2007
BerGenBio ASA— Founded

Drugs by trial phase (19 distinct, 15 trials)

Phase 2 (17 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT05469178Lead sponsorPhase 1/Phase 2Oct 31, 2022
NCT06469138Lead sponsorPhase 1Aug 2, 2022
NCT04893551Study directorPhase 1Feb 25, 2021
NCT04893551Lead sponsorPhase 1Feb 25, 2021
NCT04890509Lead sponsorPhase 2Oct 20, 2020
NCT04890509Study chairPhase 2Oct 20, 2020
NCT03965494CollaboratorEarly Phase 1Aug 1, 2019
NCT03824080CollaboratorPhase 2Dec 20, 2018
NCT03795142Lead sponsorEarly Phase 1Dec 19, 2018
NCT03649321CollaboratorPhase 1/Phase 2Nov 30, 2018
NCT03654833CollaboratorPhase 2Oct 1, 2018
NCT03184558Lead sponsorPhase 2Jun 1, 2017
NCT03184571Lead sponsorPhase 2Jun 1, 2017
NCT02872259CollaboratorPhase 1/Phase 2Jan 1, 2017
NCT02922777CollaboratorPhase 1Nov 1, 2016

Details

Founded: Bergen, NO Jun 1, 2007
Last known activity: Oct 31, 2022